Harlow, E., et al., 1988, "Immunizations", in Antibodies: A Laboratory Manual, Harlow, E., et al., eds., Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, pp. 53-137. |
Monath et al., "Flaviviruses," in Fields Virology, Third Edition, Fields et al., eds., Lippincott-Raven Publishers, Philadelphia, pp. 961-977 and 1002-1004, 1996. |
Schlesinger et al., "New approaches to flavivirus vaccine development," Biotech. 20:289-307, 1992. |
Stephenson, J., "Flavivirus vaccines," Vaccine 6:471-480, 1988. |
Rico-Hesse et al., "Molecular evolution of dengue type 2 virus in thailand," Am. J. Trop. Med. Hyg. 58(1):96-101, 1998. |
Igarashi, A., "Impact of dengue virus infection and its control," FEMS Immunol. Med. Microbiol. 18:291-300, 1997. |
Bancroft, W., "Current status of dengue vaccines and prospects for the future," PRHSJ 6(1):23-26, 1987. |
Culp et al., "Regulated expression allows high level production and secretion of HIV-1 gp120 envelope glycoprotein in drosophila schneider cells," Biotech. 9:173-177, 1991. |
de Oliveira et al., "Immunogenicity of an alum-adsorbed synthetic multiple-antigen peptide based on B-and T-cell epitopes of the Plasmodium falciparum CS protein: possible vaccine application," Vaccine 12(11):1012-1017, 1994. |
Delenda et al., "Protective efficacy in mice of a secreted form of recombinant dengue-2 virus envelope protein produced in baculovirus infected insect cells," Arch. Virol. 139(1-2):197-207, 1994(a). |
Delenda et al., "Analysis of C-terminally truncated dengue 2 and dengue 3 virus envelope glycoproteins: processing in insect cells and immunogenic properties in mice," J. Gen. Virol. 75:1569-1578, 1994(b). |
Nowak, T. and Wengler, G., "Analysis of Disulfides Present in the Membrane Proteins of the West Nile Flavivirus," Virology (1987) 156:127-137. |
Putnak, R.A., "Progress in the Development of Recombinant Vaccines Against Dengue and Other Arthopod-borne Flaviviruses," Modern Vaccinology, E. Kurstak, ed. New York: Plenum Medical, 1994, chapter 11, 231-252. |
Roehrig et al., "Mapping of Biologically Active Helper T-cell Epitopes on the Flavivirus Envelope Glycoprotein," Vaccines 92, Cold Spring Harbor Laboratory Press, 1992, p. 277-281. |
Srivastava, A.K. et al., "Immunogenicity of Peptides Cleaved by Cyanogen Bromide from Japanese Encephalitis Virus Envelope Glycoprotein E," Acta Virol (1990) 34:228-238. |
Srivastava, A.K. et al., "Japanese Encephalitis Virus Fusion Protein with Protein A Expressed in Escherichia coli Confers Protective Immunity in Mice," Microbiol Immunol (1991) 35:863-870. |
Trirawatanapong, T. et al., "Mapping of a region of dengue virus type-2 glycoprotein required for binding by a neutralizing monoclonal antibody," Gene (1992) 116:139-150. |
Brandt, E.E., "Development of Dengue and Japanese Encephilitis Vaccines,"J. Infect Disease (1990) 162:577-583. |
Chambers, T.J. et al., "Flavivirus Genome Organization, Expression and Replication," Annual Rev Microbiol (1990) 44:649-688. |
Hahn, Y.S. et al., "Nucleotide Sequence of Dengue 2 RNA and Comparison of the Encoded Proteins with Those of Other Flaviviruses," Virology (1988) 162:167-180. |
Halstead, S.B., "Pathogenesis of Dengue: Challenges to Molecular Biology," Science (1988) 239:476-481. |
Henchal, E.A. and Putnak, J.R., "The Dengue Viruses," Clin Microbiol Rev. (1990) 3:376-396. |
Jan, L., et al., "Increased Immunogenicity and Protective Efficacy in Outbread and Inbread Mice by Strategic Carboxyl-Terminal Truncation of Japanese Encephalitis Virus Envelope Glycoprotein," Am. J. Trop. Med. Hyg., 48(3), (1993) pp. 412-423. |
Mandl, C.W. et al., "Antigenic Structure of the Flavivirus Envelope Protein E at the Molecular Level, Using Tick-Borne Encephalitis Virus as a Model," Virology (1989) 63:564-571. |
Mason, P.W. et al., "The antigenic structure of dengue type 1 virus envelope and NS1 proteins expressed in Escherichia coli," J. Gen. Virol (1990) 71:2107-2114. |
Mason, P.W., et al., "Molecular Characterization of a Neutralizing Domain of the Japanese Encephilitis Virus Structural Glycoprotein," J. Gen Virol (1989) 70:2037-2048. |
Megret, F. et al., "Use of Recombinant Fusion Proteins and Monoclonal Antibodies to Define Linear and Discontinuous Antigenic Sites on the Dengue Virus Envelope Gylcoprotein," Virlogy (1992) 187:480-491. |
Men, R. et al., "Carboxy-Terminally Truncated Dengue Virus Envelope Glycoproteins Expressed on the Cell Surface and Secreted Extracellularly Exhibit Increased Immunogenicity in Mice," J. Virol (1991) 65:1400-1407. |
Winkler, G. et al., "Characterization of a Disulphide Bridge-stabilized Antigenic Domain of Tick-borne Encephalitis Virus Structural Glycoprotein," J. Gen Virol (1987) 68:2239-2244. |
Control of Virus Disease, Second Edition 1993. |